You searched for Simon Brassel

Office of Health Economics

OHE

Leading intellectual authority on global health economics

Search publications, topics, authors and more

Newsletter SignupSubscribe

All Topics
Health Technology Assessment (HTA)
Antimicrobial Resistance (AMR)

OHE

Newsletter SignupSubscribe

Search publications, topics, authors and more

OHE

Research & Publications
News & Insights
Education
Innovation Policy Prize

Events
About Us
OHE Experts
Contact Us

Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:

Antimicrobial Resistance (AMR)
Biosimilars
Cell and Gene Therapies
Chronic Diseases
Combination Therapies
COVID-19 Research
Digital Health
Drug Development/R&D
Emerging Markets
EQ-5D and PROMs
Health Care Systems
Health Data and Statistics
Health Technology Assessment
Precision Medicine
Real-World Evidence
Use of Medicines
Value-Based Pricing
Vaccine Research

Economics of Innovation
Measuring and Valuing Outcomes
Policy, Organisation and Incentives in Health Systems
Value, Affordability and Decision Making

News & Insights

News
Events
Insights
Bulletin

Education

Education Hub
OHE Graduate School
EVIA Programme
IRA Programme

Innovation Policy Prize

The Prize Fund
2022 Prize Fund

Search publications, topics, authors and more

Latest Research & Publications

Precision Medicine
Economics of Innovation

The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe

Antimicrobial Resistance (AMR)
Economics of Innovation

A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance

Health Technology Assessment…
Value, Affordability, and…
Pricing and Reimbursement

Real-World Evidence: Current Best Practice for Reimbursement Decision-Making

Value-Based Pricing
Economics of Innovation
Pricing and Reimbursement

Delivering the Triple Win: A Value-Based Approach to Pricing

Antimicrobial Resistance (AMR)
Economics of Innovation

Incentivising New Antibiotics: Designing a Value-Based Delinked Pull Incentive Mechanism

Digital Health

Navigating the Landscape of Digital Health – United Kingdom

All Publications

Filter by:

Antimicrobial Resistance (AMR)

Biosimilars

Cell and Gene Therapies

Chronic Diseases

Combination Therapies

COVID-19 Research

Digital Health

Drug Development/R&D

Emerging Markets

EQ-5D and PROMs

Health Care Systems

Health Data and Statistics

Health Technology Assessment

Precision Medicine

Real-World Evidence

Use of Medicines

Value-Based Pricing

Vaccine Research

Economics of Innovation

Measuring and Valuing Outcomes

Policy, Organisation and Incentives in Health Systems

Value, Affordability and Decision Making
News

Events

Insights

Bulletin
Education Hub

OHE Graduate School

EVIA Programme

IRA Programme
The Prize Fund

2022 Prize Fund

Events
About Us
OHE Experts
Contact Us

Newsletter SignupSubscribe

Filter results by

Theme

Select the product option you would like to filter Theme

Economics of Innovation Measuring and Valuing Outcomes Policy, Organisation and Incentives in Health Systems Value, Affordability, and Decision Making

Topic

Select the product option you would like to filter Topic

Antimicrobial Resistance (AMR) Biosimilars Cell and Gene Therapies Chronic Diseases Combination Therapies COVID-19 Research Digital Health Drug Development/R&D Educational Emerging Markets EQ-5D and PROMs Health Care Systems Health Data and Statistics Health Technology Assessment (HTA) Healthcare Systems Innovation Policy Prize OHE Consulting Precision Medicine Real World Evidence (RWE) Research Universal Health Coverage Use of Medicines Vaccines Value-Based Pricing

Tag

Select the product option you would like to filter Tag

Cancer Cardiovascular Disorders Caring burden Clinical Outcomes Commentary Competition Determining Value Economic Evaluation Epidemiology and Public Health Featured Gene therapies Generics Health Policy and Regulation Healthcare Delivery Healthcare Expenditure Healthcare Funding Infectious Diseases Inflation Reduction Act Injury and Trauma Innovation Market Access Mental Health Pharmaceutical Industry Policy Analysis Pricing and Reimbursement Primary Care Quality of Care Quality of Life Rare and Orphan Diseases Research Funding Resource Allocation Sustainability Value based pricing

Date 1

Select the product option you would like to filter Date

Date From

Month From

Year From

Date To

Month To

Year To

Author

Select the product option you would like to filter Author

Search authors

Megan Skingle Helen Hayes Tanja Podkonjak Luigi Siciliani Bert Vrijhoef Iris Boot Jason Chia-Hsun Hsieh Raoh-Fang Pwu Claudio Jommi Matthias Hofer

Content Type

Select the product option you would like to filter Content Type

news story insight events podcast bulletin publications

Precision Medicine
Economics of Innovation

The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe

European Union flag on the background of old locked doors

Insight
May 2023

New Drugs to Tackle Antimicrobial Resistance: Breaking the European Deadlock: Part 1 – Defining Objectives

White prescription pills on United States flag

Bulletin
May 2023

May 2023

On the dollar money are white medicine pills.

Insight
May 2023

The US Inflation Reduction Act: what do the experts think?

Insight
May 2023

Around The World in HTAs: The Netherlands – 5 Routes for New Tech

Slovak discounting_andrik-langfield-0rTCXZM7Xfo-unsplash_landscape

Insight
May 2023

Setting the Right Discount Rate for HTA in the Slovak Republic

Event
OHE Webinar
Sponsored Webinar
May 2023

Supporting Sustainability in the Era of Green Pharmaceuticals

Antimicrobial Resistance (AMR)
Economics of Innovation

A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance

Health Technology Assessment…
Value, Affordability, and…
Pricing and Reimbursement

Real-World Evidence: Current Best Practice for Reimbursement Decision-Making

IRA-course-graphic-for-website-news-FINAL-1

News
May 2023

New free educational program launched – Explaining the U.S. Inflation Reduction Act

Past Event
May 2023

OHE at ISPOR 2023

Insight
April 2023

How Restrictive are NICE ‘Optimised’ Decisions?

Implementation_AdobeStock_272343634_landscape

Bulletin
April 2023

April 2023

Value-Based Pricing
Economics of Innovation
Pricing and Reimbursement

Delivering the Triple Win: A Value-Based Approach to Pricing

Italy_Balloon_AdobeStock_177931475_landscape

Insight
April 2023

Around The World in HTAs: Italy – What’s Next?

Past Event
Seminar
April 2023

Cell & Gene Therapies: Can We Find Innovative Ways to Pay?

Leading intellectual authority on global health economics

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Cookies Policy

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Twitter

Facebook

Copy

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Enable or Disable Cookies

Please enable Strictly Necessary Cookies first so that we can save your preferences!

Latest Research & Publications

The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe

A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance

Real-World Evidence: Current Best Practice for Reimbursement Decision-Making

Delivering the Triple Win: A Value-Based Approach to Pricing

Incentivising New Antibiotics: Designing a Value-Based Delinked Pull Incentive Mechanism

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

Navigating the Landscape of Digital Health – United Kingdom

2021 OHE Annual Report to the Charity Commission

All Publications

Filter results by

The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe

New Drugs to Tackle Antimicrobial Resistance: Breaking the European Deadlock: Part 1 – Defining Objectives

May 2023

The US Inflation Reduction Act: what do the experts think?

Around The World in HTAs: The Netherlands – 5 Routes for New Tech

Setting the Right Discount Rate for HTA in the Slovak Republic

Supporting Sustainability in the Era of Green Pharmaceuticals

A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance

Real-World Evidence: Current Best Practice for Reimbursement Decision-Making

New free educational program launched – Explaining the U.S. Inflation Reduction Act

OHE at ISPOR 2023

How Restrictive are NICE ‘Optimised’ Decisions?

April 2023

Delivering the Triple Win: A Value-Based Approach to Pricing

Around The World in HTAs: Italy – What’s Next?

Cell & Gene Therapies: Can We Find Innovative Ways to Pay?